Tag: smart biopsy devices market revenue

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Smart Biopsy Devices Market Be Worth By 2029?

In the past years, the market size of smart biopsy devices have experienced significant growth. Seeing an increase from $2.85 billion in 2024 to $3.01 billion in 2025, it exhibits a compound annual growth rate (CAGR) of 5.6%. The growing number of cancer cases, the preference for procedures that are minimally invasive, innovations in the medical devices sector, and enhanced diagnostic precision are contributors to growth during the historic period.

Anticipated robust expansion is on the horizon for the smart biopsy devices market, as it is predicted to rise to a value of $4.01 billion by 2029, reflecting a compound annual growth rate (CAGR) of 7.4%. This significant growth forecast can be credited to several factors, such as the rise of personalized medicine, innovations in imaging modalities, an increase in biopsy for biomarker analysis, the introduction of new competitors in the market, and improved data connectivity. Key trends anticipated during the forecast period encompass robotic-assisted biopsies, artificial intelligence-enabled biopsy assistance, the creation of wireless biopsy tools, portability in handheld devices, and real-time guidance systems.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp

What Market Forces Are Contributing To The Growth Of The Smart Biopsy Devices Market?

Growth in the smart biopsy devices market is anticipated due to increasing cancer incidences. Cancer, a group of diseases that can form almost anywhere in the body due to uncontrolled and abnormal cell growth that can spread or invade nearby tissues, amplifies the need for detailed and targeted tissue samples. This growth drives the development of improved smart biopsy tools with enhanced molecular, imaging, and precision features to aid in diagnosis and treatment plans. For example, the World Health Organization, a Switzerland-based Intergovernmental organization, predicted in January 2024 that there would be over 35 million new cancer cases by 2050. This figure represents a 77% rise from the estimated 20 million cancer cases and 9.7 million deaths recorded in 2022. Therefore, the increasing incidences of cancer are fuelling the expansion of the smart biopsy device market.

Which Segments Define The Structure Of The Smart Biopsy Devices Market?

The smart biopsy devicesmarket covered in this report is segmented –

1) By Product: Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products

2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques

3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications

4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers

Subsegments:

1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices

2) By Procedure Trays: Pre-Packaged Biopsy Procedure Trays, Customizable Procedure Trays

3) By Localization Wires: Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices

4) By Other Products: Biopsy Markers, Biopsy Imaging Systems, Biopsy Guidance Systems

What Strategic Shifts And Innovations Are Influencing The Smart Biopsy Devices Market?

Leading businesses in the smart biopsy device market are introducing enhanced products such as breast biopsy markers to better the accuracy and efficiency of breast cancer diagnosis. These markers are specifically designed to identify the exact location of the tissue sample extracted during a biopsy, facilitating future treatment plans and ensuring proper monitoring of any potentially malignant regions. Take for example, in August 2022, Mammotome, a US-based medical equipment firm, unveiled the Mammotome DualCore Dual Stage Core Biopsy System, a minimally invasive breast biopsy tool that employs a two-stage system to yield accurate and high-quality tissue samples. This device is frequently used in conjunction with ultrasound assistance for a safe, accurate, and efficient diagnosis of breast cancer. When paired with advanced breast biopsy markers, this system provides medical professionals with a holistic and cutting-edge solution for ultrasound-guided breast biopsies.

Which Firms Are Making The Biggest Impact In The Smart Biopsy Devices Market?

Major companies operating in the smart biopsy devices market include Cardinal Health Inc, General Electric Company, Medtronic Plc, Danaher Corporation, Canon Medical Systems Corporation, Toshiba Corporation, Siemens Healthineers, FUJIFILM Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Hologic Inc., Cook Medical Inc., CONMED Corporation, Leica Biosystems, Argon Medical Devices Inc., Esaote SpA, SOMATEX Medical Technologies GmbH, Planmed Oy, TSK Laboratory Europe B.V., DTR Medical Ltd., INRAD Inc., Sterylab Srl, EndoMed Systems GmbH

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

Which Region Is Forecasted To Lead The Smart Biopsy Devices Market In The Coming Years?

North America was the largest region in the smart biopsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12271&type=smp

Browse Through More Reports Similar to the Global Smart Biopsy Devices Market 2025, By The Business Research Company

Milking Machines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/milking-machines-global-market-report

Cheese Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cheese-global-market-report

Refrigerated Warehousing And Storage Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/refrigerated-warehousing-and-storage-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Milestones in the Smart Biopsy Devices Market’s Growth Trajectory From 2025 To 2034?

The market for smart biopsy devices has seen significant growth in the recent past. The market size promises a growth from a value of $2.85 billion in 2024 to $3.01 billion in 2025, with a compound annual growth rate (CAGR) of 5.6%. The surge in growth during the historical period can be credited to the rise in cancer incidences, preference for minimally invasive procedures, advancements in medical device technology, and enhanced diagnostic precision.

The market for smart biopsy devices is predicted to experience significant expansion in the upcoming years, with projections suggesting it will reach a total value of $4.01 billion by 2029, with a compound annual growth rate (CAGR) of 7.4%. Factors contributing to growth during the forecast period include the expansion of personalized medicine, advancements in imaging modalities, increased utilization of biopsy for biomarker analysis, new market entrants, and improved data connectivity. Key emerging trends during the forecast period are the use of robot-assisted biopsies, AI-supported biopsy assistance, the creation of wireless biopsy tools, portable and handheld devices, along with real-time guidance systems.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Smart Biopsy Devices Market?

The escalating incidence of cancer is predicted to fuel the expansion of the smart biopsy devices market. Recognized as a widespread array of diseases, cancer can form in almost all organs or tissues, when cells multiply uncontrollably, extend beyond their normal limits, and either metastasize to other organs or invade adjacent body parts. The increasing occurrence of cancer amplified the demand for precise and targeted tissue specimens. This, in turn, has stimulated the development and progress of smart biopsy tools enhanced with superior molecular, imaging, and accuracy features to assist in diagnosis and treatment schemes. For instance, as per the World Health Organization in January 2024, a Swiss-based Intergovernmental organization, it’s projected to exceed 35 million fresh cancer instances by 2050, marking a 77% hike from the roughly predicted 20 million cases and 9.7 million fatalities recorded in 2022. Thus, the escalating cancer incidents are spurring the expansion of the smart biopsy device market.

Which Key Market Segments Comprise the Smart Biopsy Devices Market and Drive Its Revenue Growth?

The smart biopsy devicesmarket covered in this report is segmented –

1) By Product: Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products

2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques

3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications

4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers

Subsegments:

1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices

2) By Procedure Trays: Pre-Packaged Biopsy Procedure Trays, Customizable Procedure Trays

3) By Localization Wires: Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices

4) By Other Products: Biopsy Markers, Biopsy Imaging Systems, Biopsy Guidance Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12271&type=smp

Which Areas Are Leading Regions in the Smart Biopsy Devices Market Expansion Across the Globe?

North America was the largest region in the smart biopsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theSmart Biopsy Devices Market Over the Coming Years?

Leading businesses in the smart biopsy device market are developing sophisticated products like breast biopsy markers to enhance the accuracy and efficiency of breast cancer detection procedures. These markers have been tailored to precisely identify the site from where a biopsy tissue sample was taken, providing guidance for subsequent treatments and ensuring the correct region is scrutinized for potential cancer. To illustrate, in August 2022, U.S. based medical device corporation Mammotome introduced the Mammotome DualCore Dual Stage Core Biopsy System. This less invasive breast biopsy device employs a dual-stage method to yield accurate and high-quality tissue samples, frequently utilized alongside ultrasound direction for exact, safe, and effective breast cancer determination. This system can be paired with advanced breast biopsy markers to provide medical practitioners with a comprehensive and innovative approach for ultrasound-guided breast biopsies.

View the full report here:

https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

How Is the Smart Biopsy Devices Market Conceptually Defined?

Smart biopsy devices refer to intelligent instruments intended to increase the precision and efficiency of tissue samples during medical procedures. It has features such as image guidance, real-time feedback, or robotic help to improve diagnostic capabilities and patient outcomes. It is used for diagnosing cancer and delivering therapeutic drugs.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12271

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Smart Biopsy Devices Market Grown from 2024 to 2025?

In recent times, the market size for smart biopsy devices has seen significant growth. The value is projected to increase from $2.85 billion in 2024 to $3.04 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.4%. The growth during the historic period can be attributed to a rise in cancer incidents, a preference for minimally invasive procedures, advancement in medical devices, and enhanced diagnostic precision.

What Growth Rate Is Anticipated for the Smart Biopsy Devices Market in the Coming Years?

Over the coming years, the smart biopsy devices market size is predicted to experience considerable growth, escalating to a value of $4.05 billion in 2029, with a compound annual growth rate (CAGR) of 7.5%. The surge in this forecasted period can be ascribed to several factors such as the rise in personalized medicine, advancements in imaging modalities, an increase in biopsy for biomarker analysis, the entry of new players into the market, and superior data connectivity. Significant trends to look out for during the forecast period encompass robot-aided biopsies, AI-enabled biopsy assistance, the emergence of wireless biopsy instruments, utilization of portable and handheld devices, and real-time guidance systems.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp

Who Are the Leading Companies in the Smart Biopsy Devices Market?

Major companies operating in the smart biopsy devices market include Cardinal Health Inc, General Electric Company, Medtronic Plc, Danaher Corporation, Canon Medical Systems Corporation, Toshiba Corporation, Siemens Healthineers, FUJIFILM Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Hologic Inc., Cook Medical Inc., CONMED Corporation, Leica Biosystems, Argon Medical Devices Inc., Esaote SpA, SOMATEX Medical Technologies GmbH, Planmed Oy, TSK Laboratory Europe B.V., DTR Medical Ltd., INRAD Inc., Sterylab Srl, EndoMed Systems GmbH

What Are the Key Drivers of the Smart Biopsy Devices Market?

The increase in cancer incidences is anticipated to boost the expansion of the smart biopsy devices market. Cancer encompasses a wide range of diseases that can originate in almost any organ or tissue. This occurs when rogue cells multiply without control, exceeding their normal confines, and either migrate to other organs or encroach upon nearby body sections. This surge in cancer cases has intensified the demand for accurate and targeted tissue specimens, which in turn has fueled the development of sophisticated biopsy tools with enhanced molecular, imaging, and precision capabilities to facilitate diagnostic and treatment procedures. For example, the World Health Organization, a Switzerland-based Intergovernmental organization, predicted in January 2024 that there will be more than 35 million new cancer cases by 2050, representing a 77% increase from the estimated 20 million cases and 9.7 million fatalities noted in 2022. Hence, the escalating number of cancer cases is stimulating the expansion of the smart biopsy device market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12271&type=smp

What Are the Key Market Segments in the Smart Biopsy Devices Industry?

The smart biopsy devices market covered in this report is segmented –

1) By Product: Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products

2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques

3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications

4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers

Subsegments:

1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices

2) By Procedure Trays: Pre-Packaged Biopsy Procedure Trays, Customizable Procedure Trays

3) By Localization Wires: Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices

4) By Other Products: Biopsy Markers, Biopsy Imaging Systems, Biopsy Guidance Systems

What Are the Latest Trends in the Smart Biopsy Devices Market?

Leading firms in the smart biopsy device market are focusing on the creation of sophisticated products such as breast biopsy markers, with the aim of augmenting the accuracy and efficiency of breast cancer diagnosis procedures. These markers are specifically engineered to locate exactly the spot from which a tissue sample was taken during a biopsy, thereby informing future treatment plans and facilitating close monitoring of the right region for any potential transformation into malignant cells. For example, Mammotome, a medical device manufacturer based in the United States, introduced the Mammotome DualCore Dual Stage Core Biopsy System in August 2022. As a minimally invasive breast biopsy device, it employs a two-stage methodology to deliver precision and high-quality tissue samples, typically with ultrasound guidance to enable accurate, safe, and effective diagnosis of breast cancer. By integrating this system with advanced breast biopsy markers, healthcare professionals have access to an all-encompassing and progressive approach for performing ultrasound-guided breast biopsies.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

What Are the Key Regional Markets in the Smart Biopsy Devices Industry?

North America was the largest region in the smart biopsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12271

This Report Delivers Insight On:

1. How big is the smart biopsy devices market, and how is it changing globally?

2. Who are the major companies in the smart biopsy devices market, and how are they performing?

3. What are the key opportunities and risks in the smart biopsy devices market right now?

4. Which products or customer segments are growing the most in the smart biopsy devices market?

5. What factors are helping or slowing down the growth of the smart biopsy devices market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the smart biopsy devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has the Smart Biopsy Devices Market Growth Performance Trended Historically, And What Lies Ahead?

In recent times, the market size for smart biopsy devices has seen significant growth. The value is projected to increase from $2.85 billion in 2024 to $3.04 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.4%. The growth during the historic period can be attributed to a rise in cancer incidents, a preference for minimally invasive procedures, advancement in medical devices, and enhanced diagnostic precision.

Over the coming years, the smart biopsy devices market size is predicted to experience considerable growth, escalating to a value of $4.05 billion in 2029, with a compound annual growth rate (CAGR) of 7.5%. The surge in this forecasted period can be ascribed to several factors such as the rise in personalized medicine, advancements in imaging modalities, an increase in biopsy for biomarker analysis, the entry of new players into the market, and superior data connectivity. Significant trends to look out for during the forecast period encompass robot-aided biopsies, AI-enabled biopsy assistance, the emergence of wireless biopsy instruments, utilization of portable and handheld devices, and real-time guidance systems.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp

What Are the Core Market Drivers Propelling Growth in the Smart Biopsy Devices Industry?

The increase in cancer incidences is anticipated to boost the expansion of the smart biopsy devices market. Cancer encompasses a wide range of diseases that can originate in almost any organ or tissue. This occurs when rogue cells multiply without control, exceeding their normal confines, and either migrate to other organs or encroach upon nearby body sections. This surge in cancer cases has intensified the demand for accurate and targeted tissue specimens, which in turn has fueled the development of sophisticated biopsy tools with enhanced molecular, imaging, and precision capabilities to facilitate diagnostic and treatment procedures. For example, the World Health Organization, a Switzerland-based Intergovernmental organization, predicted in January 2024 that there will be more than 35 million new cancer cases by 2050, representing a 77% increase from the estimated 20 million cases and 9.7 million fatalities noted in 2022. Hence, the escalating number of cancer cases is stimulating the expansion of the smart biopsy device market.

How Is the Smart Biopsy Devices Market Segmented?

The smart biopsy devices market covered in this report is segmented –

1) By Product: Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products

2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques

3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications

4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers

Subsegments:

1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices

2) By Procedure Trays: Pre-Packaged Biopsy Procedure Trays, Customizable Procedure Trays

3) By Localization Wires: Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices

4) By Other Products: Biopsy Markers, Biopsy Imaging Systems, Biopsy Guidance Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12271&type=smp

Which Regions Are Driving the Next Phase of the Smart Biopsy Devices Market Growth?

North America was the largest region in the smart biopsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Smart Biopsy Devices Industry?

Leading firms in the smart biopsy device market are focusing on the creation of sophisticated products such as breast biopsy markers, with the aim of augmenting the accuracy and efficiency of breast cancer diagnosis procedures. These markers are specifically engineered to locate exactly the spot from which a tissue sample was taken during a biopsy, thereby informing future treatment plans and facilitating close monitoring of the right region for any potential transformation into malignant cells. For example, Mammotome, a medical device manufacturer based in the United States, introduced the Mammotome DualCore Dual Stage Core Biopsy System in August 2022. As a minimally invasive breast biopsy device, it employs a two-stage methodology to deliver precision and high-quality tissue samples, typically with ultrasound guidance to enable accurate, safe, and effective diagnosis of breast cancer. By integrating this system with advanced breast biopsy markers, healthcare professionals have access to an all-encompassing and progressive approach for performing ultrasound-guided breast biopsies.

View the full report here:

https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

How Is the Smart Biopsy Devices Market Defined and What Are Its Core Parameters?

Smart biopsy devices refer to intelligent instruments intended to increase the precision and efficiency of tissue samples during medical procedures. It has features such as image guidance, real-time feedback, or robotic help to improve diagnostic capabilities and patient outcomes. It is used for diagnosing cancer and delivering therapeutic drugs.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12271

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the smart biopsy devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has the Smart Biopsy Devices Market Growth Performance Trended Historically, And What Lies Ahead?

In recent times, the market size for smart biopsy devices has seen significant growth. The value is projected to increase from $2.85 billion in 2024 to $3.04 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.4%. The growth during the historic period can be attributed to a rise in cancer incidents, a preference for minimally invasive procedures, advancement in medical devices, and enhanced diagnostic precision.

Over the coming years, the smart biopsy devices market size is predicted to experience considerable growth, escalating to a value of $4.05 billion in 2029, with a compound annual growth rate (CAGR) of 7.5%. The surge in this forecasted period can be ascribed to several factors such as the rise in personalized medicine, advancements in imaging modalities, an increase in biopsy for biomarker analysis, the entry of new players into the market, and superior data connectivity. Significant trends to look out for during the forecast period encompass robot-aided biopsies, AI-enabled biopsy assistance, the emergence of wireless biopsy instruments, utilization of portable and handheld devices, and real-time guidance systems.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp

What Are the Core Market Drivers Propelling Growth in the Smart Biopsy Devices Industry?

The increase in cancer incidences is anticipated to boost the expansion of the smart biopsy devices market. Cancer encompasses a wide range of diseases that can originate in almost any organ or tissue. This occurs when rogue cells multiply without control, exceeding their normal confines, and either migrate to other organs or encroach upon nearby body sections. This surge in cancer cases has intensified the demand for accurate and targeted tissue specimens, which in turn has fueled the development of sophisticated biopsy tools with enhanced molecular, imaging, and precision capabilities to facilitate diagnostic and treatment procedures. For example, the World Health Organization, a Switzerland-based Intergovernmental organization, predicted in January 2024 that there will be more than 35 million new cancer cases by 2050, representing a 77% increase from the estimated 20 million cases and 9.7 million fatalities noted in 2022. Hence, the escalating number of cancer cases is stimulating the expansion of the smart biopsy device market.

How Is the Smart Biopsy Devices Market Segmented?

The smart biopsy devices market covered in this report is segmented –

1) By Product: Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products

2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques

3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications

4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers

Subsegments:

1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices

2) By Procedure Trays: Pre-Packaged Biopsy Procedure Trays, Customizable Procedure Trays

3) By Localization Wires: Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices

4) By Other Products: Biopsy Markers, Biopsy Imaging Systems, Biopsy Guidance Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12271&type=smp

Which Regions Are Driving the Next Phase of the Smart Biopsy Devices Market Growth?

North America was the largest region in the smart biopsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Smart Biopsy Devices Industry?

Leading firms in the smart biopsy device market are focusing on the creation of sophisticated products such as breast biopsy markers, with the aim of augmenting the accuracy and efficiency of breast cancer diagnosis procedures. These markers are specifically engineered to locate exactly the spot from which a tissue sample was taken during a biopsy, thereby informing future treatment plans and facilitating close monitoring of the right region for any potential transformation into malignant cells. For example, Mammotome, a medical device manufacturer based in the United States, introduced the Mammotome DualCore Dual Stage Core Biopsy System in August 2022. As a minimally invasive breast biopsy device, it employs a two-stage methodology to deliver precision and high-quality tissue samples, typically with ultrasound guidance to enable accurate, safe, and effective diagnosis of breast cancer. By integrating this system with advanced breast biopsy markers, healthcare professionals have access to an all-encompassing and progressive approach for performing ultrasound-guided breast biopsies.

View the full report here:

https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

How Is the Smart Biopsy Devices Market Defined and What Are Its Core Parameters?

Smart biopsy devices refer to intelligent instruments intended to increase the precision and efficiency of tissue samples during medical procedures. It has features such as image guidance, real-time feedback, or robotic help to improve diagnostic capabilities and patient outcomes. It is used for diagnosing cancer and delivering therapeutic drugs.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12271

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theSmart Biopsy Devices Market?

The smart biopsy devices market is predicted to grow due to the escalating rate of cancer incidences. The expansive category of diseases known as cancer consists of abnormal cells that rapidly multiply beyond their regular boundaries and either invade adjacent parts of the body or metastasize to other organs. The surge in cancer occurrences has necessitated the need for more accurate and targeted tissue sample testing. This has spurred the development and enhancement of innovative smart biopsy devices with superior molecular, imaging, and precision abilities to aid in diagnosis and treatment strategies. For instance, the World Health Organization, an Intergovernmental organization based in Switzerland, forecasts that by 2050 there will be over 35 million new cancer cases, a growth of 77% compared to the estimated 20 million cases and 9.7 million fatalities documented in 2022. Thus, the growth of the smart biopsy device market is being fueled by the escalating incidence of cancer cases.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp

#How Does the ProjectedSmart Biopsy Devices Market Growth Compare Over the Forecast Period?

The market size for smart biopsy devices has seen significant expansion in the last few years. It is projected to witness a leap from a valuation of $2.85 billion in 2024 to $3.04 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. The surge experienced during the historic timeline can be credited to the rise in cancer incidences, the preference for less invasive procedures, advancements in medical devices, and enhanced diagnostic precision.

The market for smart biopsy devices is predicted to experience significant growth in the upcoming years. The market is slated to reach a value of $4.05 billion in 2029, with a compound annual growth rate (CAGR) of 7.5%. This expansion during the forecast period is expected to be driven by factors such as the growth of personalized medicine, advancements in imaging techniques, an increase in biopsy for biomarker analysis, the emergence of new market players, and improved data connectivity. Noteworthy trends for the forecast period encompass robotic-assisted biopsies, artificial intelligence-driven biopsy support, the advent of wireless biopsy instruments, portable and handheld devices, and real-time guidance systems.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12271

What Key Market Trends and Innovations Are Shaping the Future of theSmart Biopsy Devices Industry?

Big players in the smart biopsy device market are introducing new and improved products, such as breast biopsy markers, to enhance the precision and effectiveness of breast cancer diagnostics. These markers serve to accurately identify the location of a tissue sample obtained during a biopsy, providing a roadmap for future treatments and ensuring the exact area is scrutinized for potential malignancies. For example, in August 2022, the American medical device company, Mammotome, released the Mammotome DualCore Dual Stage Core Biopsy System. This minimally invasive breast biopsy device employs a dual-stage approach to yield accurate, high-quality tissue samples. Often used in conjunction with ultrasound guidance, it assures a precise, secure, and efficient breast cancer diagnosis. By integrating this system with advanced breast biopsy markers, clinicians are presented with a cutting-edge, all-encompassing solution for ultrasound-guided breast biopsies.

Which Companies Are Leading the Charge in Expanding theSmart Biopsy Devices Market Growth?

Major companies operating in the smart biopsy devices market include Cardinal Health Inc, General Electric Company, Medtronic Plc, Danaher Corporation, Canon Medical Systems Corporation, Toshiba Corporation, Siemens Healthineers, FUJIFILM Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Hologic Inc., Cook Medical Inc., CONMED Corporation, Leica Biosystems, Argon Medical Devices Inc., Esaote SpA, SOMATEX Medical Technologies GmbH, Planmed Oy, TSK Laboratory Europe B.V., DTR Medical Ltd., INRAD Inc., Sterylab Srl, EndoMed Systems GmbH

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

How is the Global Smart Biopsy Devices Market Segemented?

The smart biopsy devices market covered in this report is segmented –

1) By Product: Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products

2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques

3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications

4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers

Subsegments:

1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices

2) By Procedure Trays: Pre-Packaged Biopsy Procedure Trays, Customizable Procedure Trays

3) By Localization Wires: Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices

4) By Other Products: Biopsy Markers, Biopsy Imaging Systems, Biopsy Guidance Systems

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12271&type=smp

Which Geographics are Influencing the Growth of the Smart Biopsy Devices Market?

North America was the largest region in the smart biopsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Smart Biopsy Devices Maret 2025, By The Business Research Company:

Dairy Processing Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dairy-processing-equipment-global-market-report

Milking Machines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/milking-machines-global-market-report

Refrigerated Warehousing And Storage Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/refrigerated-warehousing-and-storage-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the smart biopsy devices market grown in recent years?

In recent times, there has been substantial growth in the market size of smart biopsy devices. The market, expected to increase from $2.85 billion in 2024 to $3.04 billion in 2025, has a compound annual growth rate (CAGR) of 6.4%. The notable expansion during the historic period is due to the rise in cancer cases, the preference for less invasive approaches, advancements in medical devices, and superior diagnostic precision.

How is the smart biopsy devices market size expected to evolve during the forecast period?

The market size for smart biopsy devices is projected to witness robust expansion in the upcoming years, reaching $4.05 billion by 2029 at a compound annual growth rate (CAGR) of 7.5%. The predicted growth during the forecast period can be credited to the rise of personalized medicine, advances in imaging modalities, the increasing usage of biopsy for biomarker analysis, the entrance of new market players, and improved data connectivity. Major upcoming trends during this forecasted timeline include the incorporation of robotic assistance in biopsies, AI-powered biopsy assistance, the creation of wireless tools for biopsy, handheld and portable devices, as well as real-time guidance systems.

Get your smart biopsy devices market report here!

https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

Which key drivers are propelling the smart biopsy devices market’s growth?

The escalation of cancer incidents is predicted to stimulate the expansion of the smart biopsy devices market. Cancer represents a wide range of diseases that can manifest in almost any organ or tissue when abnormal cells multiply beyond control, break from their standard confines, and either penetrate other organs or invade adjacent body parts. The surge in cancer incidents necessitated the need for detailed and targeted tissue samples. This instigated the formation and enhancement of smart biopsy tools with superior molecular, imaging, and precision abilities to facilitate diagnosis and treatment plans. For example, the World Health Organization, a Switzerland-based Intergovernmental organization, reported in January 2024 that the projection is that there will be over 35 million new cancer cases by 2050. This represents a 77% increase from the estimated 20 million cases and 9.7 million deaths documented in 2022. Thus, the increasing cancer incidents are propelling the growth of the smart biopsy device market.

What are the market segments in the smart biopsy devices industry?

The smart biopsy devices market covered in this report is segmented –

1) By Product: Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products

2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques

3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications

4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers

Subsegments:

1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices

2) By Procedure Trays: Pre-Packaged Biopsy Procedure Trays, Customizable Procedure Trays

3) By Localization Wires: Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices

4) By Other Products: Biopsy Markers, Biopsy Imaging Systems, Biopsy Guidance Systems

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp

Which leading companies are shaping the growth of the smart biopsy devices market?

Major companies operating in the smart biopsy devices market include Cardinal Health Inc, General Electric Company, Medtronic Plc, Danaher Corporation, Canon Medical Systems Corporation, Toshiba Corporation, Siemens Healthineers, FUJIFILM Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Hologic Inc., Cook Medical Inc., CONMED Corporation, Leica Biosystems, Argon Medical Devices Inc., Esaote SpA, SOMATEX Medical Technologies GmbH, Planmed Oy, TSK Laboratory Europe B.V., DTR Medical Ltd., INRAD Inc., Sterylab Srl, EndoMed Systems GmbH

What key trends are currently impacting the smart biopsy devices market’s development?

Leading firms in the smart biopsy device market are developing novel products like breast biopsy markers to enhance accuracy and efficacy of breast cancer diagnosis. These markers aim to pinpoint the exact location of a tissue sample sourced during a biopsy, guiding future treatments and ensuring that the right spot is tracked for potential cancerous growth. In August 2022, Mammotome, an American medical device company, introduced the Mammotome DualCore Dual Stage Core Biopsy System. This minimally invasive breast biopsy tool employs a two-step method to deliver precise, top-quality tissue samples, and is commonly used with ultrasound guidance for accurate, safe, and efficient breast cancer recognition. This system can be integrated with innovative breast biopsy markers to provide doctors with a comprehensive and groundbreaking solution for ultrasound-directed breast biopsies.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12271

Which geographic areas are influencing the growth of the smart biopsy devices market?

North America was the largest region in the smart biopsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Dairy Processing Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dairy-processing-equipment-global-market-report

Milking Machines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/milking-machines-global-market-report

Refrigerated Warehousing And Storage Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/refrigerated-warehousing-and-storage-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Long-Term Growth Rate is Expected for the Smart Biopsy Devices Market Between 2025 and 2034?

The smart biopsy devices market has demonstrated strong growth. It is set to expand from $2.85 billion in 2024 to $3.04 billion in 2025, at a CAGR of 6.4%. Contributing factors to past growth include an increase in cancer cases, the demand for minimally invasive procedures, technological innovations in medical devices, and improved diagnostic accuracy.

The smart biopsy devices market is expected to experience strong growth, reaching $4.05 billion by 2029 at a CAGR of 7.5%. Growth factors include advancements in personalized medicine, improvements in imaging modalities, the increasing role of biopsies in biomarker analysis, market entry of new players, and enhanced data connectivity. Major trends include robot-assisted biopsies, AI-driven biopsy assistance, the emergence of wireless biopsy tools, development of portable and handheld devices, and the introduction of real-time guidance systems.

What External and Internal Drivers Are Contributing to the Growth of the Market’s Growth?

The increasing number of cancer cases is anticipated to propel the growth of the smart biopsy devices market in the future. Cancer represents a wide range of diseases that can arise in almost any organ or tissue when abnormal cells proliferate uncontrollably, breach normal boundaries, and either invade neighboring tissues or spread to other organs. The growing incidence of cancer has heightened the demand for accurate and targeted tissue samples, leading to the development of advanced smart biopsy devices with improved molecular, imaging, and precision capabilities for assisting in diagnosis and treatment planning. For example, the World Health Organization, a Switzerland-based intergovernmental organization, projected in January 2024 that there will be over 35 million new cancer cases by 2050, reflecting a 77% increase from the estimated 20 million cases and 9.7 million deaths in 2022. Thus, the rising cancer incidence is driving the smart biopsy device market’s growth.

Get Your Free Sample of the Global Smart Biopsy Devices Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp

What Are the Key Firms That Are Driving Transformation in the Smart Biopsy Devices Market?

Major companies operating in the smart biopsy devices market include:

• Cardinal Health Inc_x000D_

• General Electric Company_x000D_

• Medtronic Plc_x000D_

• Danaher Corporation_x000D_

• Canon Medical Systems Corporation_x000D_

What Current Trends in the Smart Biopsy Devices Market Should Industry Players Pay Attention To?

Technological advancements are driving innovation in the smart biopsy device market. Leading companies in this sector are developing advanced products, such as breast biopsy markers, to improve diagnostic precision and effectiveness in breast cancer detection. These markers help accurately identify the biopsy site, aiding in treatment and monitoring for malignancies. For example, in August 2022, Mammotome, a US-based medical device company, launched the Mammotome DualCore Dual Stage Core Biopsy System. This minimally invasive device enhances biopsy accuracy through a dual-stage process and is often used with ultrasound guidance, offering a comprehensive solution for breast cancer diagnosis.

Get Instant Access to the Global Smart Biopsy Devices Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

What Are the Primary Segments of the Smart Biopsy Devices Market and Their Roles in Growth Dynamics?

The smart biopsy devices market covered in this report is segmented –

1) By Product: Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products

2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques

3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications

4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers

Subsegments:

1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices

2) By Procedure Trays: Pre-Packaged Biopsy Procedure Trays, Customizable Procedure Trays

3) By Localization Wires: Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices

4) By Other Products: Biopsy Markers, Biopsy Imaging Systems, Biopsy Guidance Systems

What Regions Are Driving Expansion in the Smart Biopsy Devices Market?

North America was the largest region in the smart biopsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Parameters Define the Smart Biopsy Devices Market’s Scope?

Smart biopsy devices refer to intelligent instruments intended to increase the precision and efficiency of tissue samples during medical procedures. It has features such as image guidance, real-time feedback, or robotic help to improve diagnostic capabilities and patient outcomes. It is used for diagnosing cancer and delivering therapeutic drugs.

Browse Through More Similar Reports By The Business Research Company:

Dairy Processing Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dairy-processing-equipment-global-market-report

Milking Machines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/milking-machines-global-market-report

Refrigerated Warehousing And Storage Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/refrigerated-warehousing-and-storage-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: